Discussion on: Quality by Design Based Pharmaceutical Development Report of Cost-effective Dexamethasone Tablets, 20 mg for Regulatory Submission

Discussion: Scholarly discussion on any scientific article is very important for the advancement of science. We strongly suggest all readers and authors to participate in such activities. Comment posting facility is available at the end of this page. Comment should meet the minimum standard of scientific discussion. Personal communication, personal attack, abusive language, etc are not allowed and comments will be moderated.

Article Title

Quality by Design Based Pharmaceutical Development Report of Cost-effective Dexamethasone Tablets, 20 mg for Regulatory Submission

Authored by

Packiaraj Jeyachandran Manohari
Eywa Hibrow Pharma Private Limited and Nutrimed Lifesciences Private Limited, #258, Thiruvandavar Village, Sirupinayur Panchayat, Kanchipuram District – 603308, Chennai, Tamil Nadu, India.

Venkateswaran Chidambaram Seshadri
Eywa Hibrow Pharma Private Limited and Nutrimed Lifesciences Private Limited, #258, Thiruvandavar Village, Sirupinayur Panchayat, Kanchipuram District – 603308, Chennai, Tamil Nadu, India.

Induprasad Munirathnam
Eywa Hibrow Pharma Private Limited and Nutrimed Lifesciences Private Limited, #258, Thiruvandavar Village, Sirupinayur Panchayat, Kanchipuram District – 603308, Chennai, Tamil Nadu, India.

Aravind Aari Ramesh
Sri Ramachandra Institute of Higher Education and Research, No.1 Ramachandra Nagar, Porur, Chennai – 600116, Tamil Nadu, India.

Janakiraman Kunchithapatham
Department of Pharmacy, Annamalai University, Chidambaram – 608002, Tamil Nadu, India.

Saba Maanvizhi
Sri Ramachandra Institute of Higher Education and Research, No.1 Ramachandra Nagar, Porur, Chennai – 600116, Tamil Nadu, India.

DOI or Article Link

https://doi.org/10.9734/jpri/2025/v37i57696

Leave a Comment